CytoDyn (QB) Stock Price

0.00 (0.0%)
Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
CytoDyn Inc (QB) CYDY OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 3.40 10:23:59
Close Price Low Price High Price Open Price Previous Close
3.39 3.45 3.42 3.40
Bid Price Ask Price Spread News
3.39 3.41 0.02 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
318 223,199 $ 3.4096 $ 761,017 7,852,852 0.261 - 10.01
Last Trade Time Type Quantity Stock Price Currency
10:23:10 1,000 $ 3.40 USD

CytoDyn (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.94B 569.32M 302.11M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
26.54M $ - 0.00% - -

more financials information »

CytoDyn (QB) News

Date Time Source News Article
9/15/202017:06Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)
9/14/202016:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(7) (424b7)
9/14/202010:10InvestorsHub NewsWireSA Breaking News: ALYI - Alternet Systems revenue surging..
9/03/202008:45InvestorsHub NewsWireTraders News Source Identifies Tomorrows NASDAQ's
9/01/202017:34Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)
9/01/202014:57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
9/01/202013:47Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CYDY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.,592,030-0.72-17.48%
1 Month3.955.153.003.923,910,091-0.55-13.92%
3 Months9.6610.012.764.797,436,244-6.26-64.8%
6 Months0.99510.010.9113.997,589,5692.41241.71%
1 Year0.389810.010.2613.274,993,1733.01772.24%
3 Years0.6410.010.05522.951,895,5962.76431.25%
5 Years0.7710.010.05522.791,227,7222.63341.56%

CytoDyn (QB) Description

CytoDyn Inc. is a late-stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of Human Immunodeficiency Virus (HIV), Cancer, and Immunology.
Your Recent History
CytoDyn (Q..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200922 14:39:09